Winner Profile
Chuyuan Li
CEO, Guangzhou Baiyunshan Pharmaceutical
Industry: Health Care Distributors
Company size: X-Large
Published: 2017-12-08
Is Guangzhou Baiyunshan Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Chuyuan Li (Guangzhou Baiyunshan Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Chuyuan Li
| Year | Pin | Category |
|---|---|---|
| 2017 |  |
Investment Performance |
Chuyuan Li was included in the competition among China 100 Ranking (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Chuyuan Li
In summary, Chuyuan Li obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 43 in Combined Performance indicates that Chuyuan Li was better than 43% of all other CEOs that were analyzed as part of the China 100 Ranking – China for one participation in Obermatt CEO competitions. Chuyuan Li’s average ranking can be found in the Multi-Year Rankings for China 100 Ranking - China.